Consolidated Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7727404

Concept 2017-01-01 to
2017-12-31
As at
2017-12-31
2017-01-01 to
2017-12-31
2016-01-01 to
2016-12-31
2016-01-01 to
2016-12-31
As at
2016-12-31
As at
2015-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-733,380,000 JPY
-759,199,000 JPY
-288,926,000 JPY
-262,215,000 JPY
Depreciation
12,114,000 JPY
21,801,000 JPY
Impairment losses
21,884,000 JPY
25,811,000 JPY
Interest expenses
6,901,000 JPY
5,660,000 JPY
Foreign exchange losses (gains)
1,414,000 JPY
12,248,000 JPY
Subtotal
-566,297,000 JPY
-411,251,000 JPY
Decrease (increase) in trade receivables
29,531,000 JPY
68,459,000 JPY
Decrease (increase) in inventories
3,925,000 JPY
4,059,000 JPY
Net cash provided by (used in) operating activities
-561,055,000 JPY
-452,967,000 JPY
Increase (decrease) in trade payables
-482,000 JPY
-11,904,000 JPY
Other, net
22,010,000 JPY
-59,525,000 JPY
Interest paid
-6,872,000 JPY
-5,809,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-38,013,000 JPY
-31,070,000 JPY
Net cash provided by (used in) investing activities
-38,131,000 JPY
248,004,000 JPY
Proceeds from sale of investment securities
JPY
281,876,000 JPY
Other, net
JPY
-2,802,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
JPY
197,382,000 JPY
Proceeds from long-term borrowings
100,000,000 JPY
400,000,000 JPY
Repayments of long-term borrowings
-145,600,000 JPY
-115,898,000 JPY
Redemption of bonds
-28,028,000 JPY
JPY
Net cash provided by (used in) financing activities
295,814,000 JPY
754,897,000 JPY
Other, net
-99,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-1,595,000 JPY
-13,689,000 JPY
Net increase (decrease) in cash and cash equivalents
-304,967,000 JPY
536,244,000 JPY
Cash and cash equivalents
1,856,218,000 JPY
2,161,186,000 JPY
1,624,941,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.